Related by context. All words. (Click for frequent words.) 59 stratify patients 59 stratifying patients 59 predictive biomarker 58 stratify 57 stratified 57 carotid plaque 57 cytologic 57 LV dysfunction 56 stratifies 56 prognostic biomarker 56 subclinical atherosclerosis 56 Reynolds Risk Score 56 preoperative PSA 56 covariate 55 Charlson comorbidity index 55 cystatin 55 logistic regression model 55 Haptoglobin 55 carotid plaques 55 prostate cancer CaP 55 prognostic indicator 55 KRAS mutation status 55 gastric cardia 55 pretransplant 55 TT genotype 55 prognostic 55 metaplasia 54 multivariate Cox 54 bladder carcinoma 54 tumor histology 54 prognostic indicators 54 hematopoietic cancers 54 risk stratification 54 mutated K ras 54 perfusion CT 54 interobserver reliability 54 chemosensitivity 54 multivariable Cox 54 HER2 expression 54 PD2i ® 54 clinico pathological 54 polygenic 54 MiCK assay 53 leukocyte count 53 CHADS2 53 prognostically 53 T1a 53 colorectal adenoma 53 florbetaben 53 carotid IMT 53 HIV HCV coinfected 53 Framingham Risk Score 53 HGPIN 53 pre malignant lesions 53 osteopenic 53 CORE OM 53 independent prognostic marker 53 prostate cancer PCa 53 surrogate markers 53 ASCUS 53 Charlson Comorbidity Index 53 System IPSS 53 EGFR mutation status 53 prognostic marker 53 International Prognostic Scoring 53 univariate analysis 53 histologic subtype 53 = #.#-#.# 53 HRCT 53 Socioeconomic status 53 PSA nadir 53 FFR measurements 53 prostate carcinoma 53 thiopurine 53 histological subtype 53 serum PSA 53 atherothrombotic 52 coronary artery calcium 52 randomizing patients 52 specific antigen PSA 52 etiologic 52 locoregional recurrence 52 biopsy Gleason 52 HER2 overexpression 52 indolent lymphomas 52 operable breast cancer 52 microsatellite instability 52 PCa 52 percutaneous biopsy 52 kidney allograft 52 clinicopathological 52 logistic regression analysis 52 subclinical disease 52 aortic calcification 52 perfusion abnormalities 52 MDRD 52 univariate 52 extracapsular extension 52 postoperative AF 52 SLNB 52 polyp recurrence 52 serum albumin 52 CYP#D# genotype 52 biochemical recurrence 52 abnormal glucose metabolism 52 advanced neoplasia 52 immunochemical fecal occult 52 serum PTH 52 metachronous 52 elevated CRP 52 childhood leukaemias 52 nonmetastatic 52 Lp PLA2 51 genomic alterations 51 diffusion tensor 51 intact parathyroid hormone 51 tumor subtype 51 confidence intervals CIs 51 pancreatic adenocarcinoma 51 arterial thickening 51 multivariable adjusted 51 malignant phenotype 51 BRCA1 mutations 51 generalized estimating 51 obstructive coronary artery 51 hydroxyvitamin D concentrations 51 T1DM 51 ovarian carcinoma 51 androgen deficiency 51 echocardiographic parameters 51 humoral responses 51 pharmacogenetic testing 51 clinicopathologic 51 ICD implantation 51 nomogram 51 pT3 51 multivariable analysis 51 Rectal cancer 51 APOE genotype 51 nodal metastasis 51 PD2i R 51 debulking surgery 51 Surgical resection 51 multivariate analyzes 51 adjuvant therapies 51 genomewide 51 lowering blood glucose 51 bivariate 51 renal cysts 51 IPAH 51 prognostic variables 51 EQ 5D 51 prognostic markers 51 myocardial viability 51 abdominal adiposity 51 metastatic lymph nodes 51 F FDG PET 51 FISH fluorescence 51 CIN2 + 51 odds ratios ORs 51 EGFR mutation positive 51 elevated homocysteine 51 antibody titer 51 carcinoids 51 tertiles 51 treat NNT 51 hormone receptor negative 51 interobserver 51 plasma folate 51 immunohistochemical analysis 51 KRAS mutation 51 undergoing radical prostatectomy 51 nonalcoholic steatohepatitis NASH 51 presymptomatic 51 NMIBC 50 renal tumors 50 telomere lengths 50 urothelial carcinoma 50 prognostic factor 50 acute leukemias 50 Kaplan Meier 50 gene polymorphism 50 immunologically matched 50 liver metastasis 50 prognostic significance 50 intima media thickness 50 carotid artery intima media 50 T1c 50 hormone receptor status 50 Doppler sonography 50 bioavailable testosterone 50 Subgroup analyzes 50 Lp PLA 2 50 multivariate adjusted 50 nonischemic 50 carotid bruit 50 tHcy 50 chronic periodontitis 50 thyroid carcinoma 50 chromosomal rearrangement 50 atherogenic 50 T2DM 50 mononuclear cell 50 CC genotype 50 ICD therapy 50 acetabular fractures 50 familial predisposition 50 undergoing coronary angiography 50 binary logistic regression 50 adiponectin concentrations 50 serum biomarkers 50 antiangiogenic therapy 50 BMI waist circumference 50 familial clustering 50 obstructive CAD 50 urothelial bladder cancer 50 anthropometric measures 50 covariance 50 spontaneous regression 50 diagnostic biomarker 50 intrahepatic 50 allele frequencies 50 APOE e4 gene 50 mCRPC 50 MetS 50 cTnT 50 nephron sparing surgery 50 pretest probability 50 Kaplan Meier analysis 50 pCR 50 ECD kidneys 50 phenotypic expression 50 prospectively defined 50 coronary stenosis 50 ABL1 50 carotid intima media 50 PITX2 50 arterial calcification 50 multicentric 50 pathologic diagnosis 50 hyperplastic polyps 50 K ras mutations 50 lymph node involvement 50 postoperative complication 50 cisplatin resistant 50 immunosuppression therapy 50 confidence interval #.#-#.# 50 predictive biomarkers 50 cirrhotic patients 50 varicoceles 50 sociodemographic characteristics 50 urolithiasis 50 antibody mediated 50 aortic atherosclerosis 50 oncologic outcomes 50 conditional logistic regression 50 preoperative diagnosis 50 oxidative stress markers 50 atherothrombosis 50 HNSCC 50 Immunohistochemical staining 50 plasma lipid 50 neoadjuvant chemotherapy 50 T2D 50 heterozygotes 50 clonogenic 50 hepatic fibrosis 50 neutrophil counts 50 resectable pancreatic cancer 50 somatoform disorders 50 comorbid conditions 50 pulmonary metastasis 50 diabetes mellitus DM 50 FDG PET 50 adverse cytogenetics 50 creatine kinase MB 50 micrometastasis 50 noncancer 50 5q 50 gastric adenocarcinoma 50 CSF biomarkers 50 PROSTVAC VF 50 CHD mortality 50 clinically localized prostate 49 QRISK 49 Mantel Haenszel 49 hypogonadal 49 SCr 49 postoperative radiotherapy 49 atherothrombotic disease 49 Breslow thickness 49 attain statistical significance 49 lymph node metastasis 49 CR nPR 49 BRCA1 mutation carriers 49 variant allele 49 squamous 49 serum urate levels 49 Prognostic 49 dosimetric 49 multivessel disease 49 prothrombotic 49 ontogenetic 49 inflammatory biomarkers 49 abnormal lipid 49 explanatory variables 49 linkage disequilibrium 49 sociodemographic factors 49 serum ALT 49 TNM staging 49 apo E 49 transrectal ultrasound guided 49 platelet reactivity 49 multivariable adjustment 49 APOC3 49 stratification 49 refractory colorectal cancer 49 Prognostic factors 49 molecular subtypes 49 multivariate regression 49 biochemical relapse 49 Lymph node 49 aneurysmal 49 nonalcoholic steatohepatitis 49 abnormal cytology 49 lesional 49 antiangiogenic agent 49 TMPRSS2 ERG fusion 49 atherogenic dyslipidemia 49 immunohistochemical staining 49 electron beam computed tomography 49 benign thyroid nodules 49 IntroductionThe 49 microvessel 49 metabolomic profiling 49 nomograms 49 discriminant analysis 49 ratio WHR 49 K ras mutation 49 MYH9 49 LVSD 49 tumor subtypes 49 myeloperoxidase 49 intraobserver 49 univariate analyzes 49 adenomatous polyps 49 T SPOT.TB 49 lowering LDL cholesterol 49 nonparametric 49 TOP2A 49 correlating 49 hormone refractory 49 nondiabetic patients 49 hematologic malignancy 49 recursive partitioning 49 pharmacologic intervention 49 gastric carcinoma 49 ligand induced 49 axial length 49 FDG-PET/CT 49 ovarian malignancy 49 dichotomized 49 noncarriers 49 biomarker 49 glycosylated hemoglobin levels 49 radiotherapy RT 49 hyper IgE syndrome 49 cystatin C 49 Kaplan Meier curve 49 CaPSURE 49 morphologic 49 baseline FEV 49 lactate dehydrogenase LDH 49 BMI z 49 highest tertile 49 central adiposity 49 comorbidity 49 posttransplant 49 Li Fraumeni 49 Multiple logistic regression 49 differential gene expression 49 noncardiac 49 apolipoproteins 49 psychiatric comorbidities 49 metabolomic profiles 49 generalisable 49 adnexal mass 49 logistic regression models 49 anti leukemic 49 BI RADS 49 immunohistochemical 49 p tau 49 residual confounding 49 susceptibility loci 49 ROC curves 49 MYCN amplification 49 peripheral insulin sensitivity 49 d dimer 49 CVD mortality 49 cardiac troponin 49 observational cohort 49 hsCRP 49 relapsed ALL 49 serum IGF 49 histological subtypes 49 Coronary artery calcium 49 CaP 49 nodal metastases 49 serum ferritin 49 radical prostatectomy RP 49 microscopic colitis 49 SUVmax 49 BEXXAR Therapeutic Regimen 49 curative resection 49 % CI #.#-#.# [006] 49 OnDose TM 49 eGFR 49 mL/min/#.# m 2 48 HSCT 48 Visual Analogue Scale VAS 48 waist girth 48 posttreatment 48 median survivals 48 cardioembolic stroke 48 core needle biopsies 48 prostate carcinogenesis 48 LDL HDL 48 inferential statistics 48 visceral adiposity 48 p# mutation 48 non squamous histology 48 atherosclerotic disease 48 revascularized 48 DEXA scan 48 CHEK2 48 regression equations 48 alpha defensin 48 Coronary CTA 48 CK # plasma concentrations 48 peritoneal carcinomatosis 48 systolic dysfunction 48 incomplete revascularization 48 body fatness 48 gene amplification 48 MDRD equation 48 PSADT 48 lymphocyte count 48 cranial irradiation 48 lowest tertile 48 mucinous 48 immunoregulatory 48 KRAS status 48 molecular biomarkers 48 multivariate logistic regression 48 epithelial ovarian cancer 48 beta carotene supplementation 48 periprocedural MI 48 Glomerular filtration rate 48 precursor lesions 48 Genotypic 48 lactate dehydrogenase 48 penetrance 48 elevated LDH 48 hs CRP 48 pelvic lymphadenectomy 48 nitrotyrosine 48 cytoreduction 48 neoplastic lesions 48 dysplastic 48 HER2 positive cancers 48 supratentorial 48 cervical carcinoma 48 statistically significant correlation 48 fig. S4 48 amnestic MCI 48 LVNC 48 correlation coefficients 48 interobserver agreement 48 Trofex 48 chronicity 48 nephron 48 Leydig cell 48 epithelial tumors 48 lymphovascular invasion 48 Histological 48 nucleoside naive patients 48 quasispecies 48 Secondary efficacy endpoints 48 immunostaining 48 IQR 48 tumor excision 48 nonfasting triglyceride levels 48 differentiate squamous 48 serum biomarker 48 preoperative intraoperative 48 lethal arrhythmias 48 PITX2 methylation 48 #q# deletion syndrome 48 meta analytic 48 genetic determinants 48 chemoresistant 48 androgen suppression 48 transgene expression 48 scintigraphic 48 hemodynamically significant 48 Cardiotoxicity 48 PTPN# 48 genomic biomarker 48 mammographic density 48 logistic regression analyzes 48 histologically proven 48 Radical prostatectomy 48 biochemical marker 48 sDNA 48 #.#ng/ml 48 prostatic adenocarcinoma 48 multiple linear regression 48 genomic variation 48 waist circumference WC 48 glomerular filtration 48 LDL particle 48 localized renal 48 fructosamine 48 HbA1C levels 48 p# Shc 48 DHEA supplementation 48 cytoreductive nephrectomy 48 elevated serum ALT 48 Angiotensin converting enzyme 48 sensitivity specificity 48 proximal colon 48 bone metastasis 48 AKT1 mutation 48 axillary dissection 48 putative biomarkers 48 serum CRP 48 neovascular 48 QRS interval 48 PROLARIS 48 castrate resistant prostate cancer 48 metabolic syndrome MetS 48 MTHFR gene 48 sonographic diagnosis 48 dihydropyridine 48 resected pancreatic cancer 48 conventional angiography 48 ECOG PS 48 Preoperative 48 BRCA2 mutations 48 lobular carcinomas 48 heterogeneity 48 left ventricular LV 48 curative therapy 48 TroVax ® 48 coronary anatomy 48 Annexin V 48 lipid lowering therapy 48 underwent resection 48 apolipoprotein B 48 segmenting 48 histologies 48 μmol L 48 chromosomal mutations 48 treating neuropathic pain 48 fractional anisotropy 48 precancerous tissues 48 gene polymorphisms 48 coronary artery calcification 48 lipid elevations 48 cerebral microbleeds 48 serum IgE 48 genetic variants associated 48 androgen deprivation 48 surgically resected 48 T2 lesions 48 advanced adenoma 48 relapsed MM 48 aminotransferase levels 48 rs# [004] 48 genotypic resistance 48 sonographically guided 48 albumin excretion rate 48 CYP#D# gene 48 atherogenesis 48 EGFR tyrosine kinase inhibitors 48 kinase inhibition 48 soluble CD# ligand 48 prostate bladder 48 osteosarcomas 48 Kaplan Meier method 48 APOL1 48 TIMP 1 48 familial aggregation 48 PCNSL 48 FEV ^ sub 48 HOMA IR 48 Uncontrolled hypertension 48 VTE prophylaxis 48 histopathologic findings 48 GH deficiency 48 transvaginal sonography 48 NSTE ACS 48 ultrasonographic 48 histologic subtypes 48 BRCA1 BRCA2 48 hemodilution 48 enteroviral 48 multivariable logistic regression 48 GH deficient 48 lung nodule 48 metabolic disturbances 48 NNRTI resistant virus 48 colorectal tumor 48 elevated triglyceride levels 48 cTnI 48 Adjuvant chemotherapy 48 IL#B 48 serum parathyroid hormone 48 SELENA SLEDAI 48 lobular involution 48 disaggregating 48 multifactorial disease 47 PSQI 47 null responder 47 multivariate adjustment 47 lipoprotein cholesterol 47 cyclin E 47 statistically nonsignificant 47 completely resected 47 MS DRG 47 hip BMD 47 renal cortical 47 Multivariate analyzes 47 atypical hyperplasia 47 endothelial activation 47 prostatic tissue 47 Doxil ® 47 atheromatous 47 #F FDG PET 47 autonomic dysfunction 47 estimated GFR 47 therapeutic radiopharmaceuticals 47 allogeneic HSCT 47 tissue oxygenation 47 cardiac perfusion 47 hip resurfacing arthroplasty 47 histologic 47 ImmuKnow assay 47 seminal vesicle invasion 47 quantile 47 pathogenetic 47 interindividual 47 Recurrence Score 47 estimated glomerular filtration 47 Kaplan Meier estimates 47 proton MR spectroscopy 47 poor metabolizers 47 confounder 47 preoperative staging 47 advanced adenomas 47 BRCA mutation carriers 47 socioeconomic deprivation 47 etiologic factors 47 mTOR inhibitors 47 coronary calcium 47 APOE e4 47 pre eclamptic 47 monophasic 47 renal osteodystrophy 47 troponin T 47 cardiac troponin T 47 sequence homology 47 sirolimus eluting stents 47 HNPCC 47 subgroup analyzes 47 cervical lymph nodes 47 Monogram Trofile Assay 47 % CI #.#-#.# [008] 47 hsCRP levels 47 LHRH receptor positive 47 endometrioid 47 metabolic dysregulation 47 cerebral oximetry 47 histologically 47 aggrecan 47 gefitinib Iressa 47 lymphoid tumors 47 biomarker assay 47 multivariable 47 radical nephrectomy 47 ErbB2 positive 47 Treg cell 47 dyssynchrony 47 intravenous thrombolysis 47 lymphadenectomy 47 lipid lowering drugs 47 extramedullary 47 vertebral fracture 47 cTnT levels 47 coronary CTA 47 antihypertensive agents 47 ABCB1 47 microdeletions 47 urine dipstick 47 induced sputum 47 autologous transplantation 47 tumor biopsies 47 FDG PET scans 47 hemoglobin Hb 47 human leukocyte antigens 47 GISTs 47 troponins 47 Supplementary Table 47 deCODE BreastCancer TM 47 cerebral oxygenation 47 hepatocellular carcinomas 47 DNA methyltransferases 47 thromboembolic disease 47 epistasis 47 MMSE score 47 causal pathway 47 OGG1 47 adenoma recurrence 47 LV hypertrophy 47 PSA kinetics 47 computed tomographic scans 47 neoplastic 47 serum creatinine levels 47 parasitaemia 47 catheter angiography 47 SNP rs# [001] 47 immunomodulation 47 melanocytic nevi 47 bone density measurements 47 hamartomas 47 PON1 47 cellularity 47 recurrent myocardial infarction 47 antiplatelet agents 47 carcinoembryonic antigen 47 mesenchymal stem cell 47 extracolonic 47 biologic plausibility 47 ImmuKnow 47 iPS derived 47 NADiA TM 47 Estrogen Receptor 47 endocrine therapies 47 visceral adipose tissue 47 colorectal neoplasia 47 longitudinal cohort study 47 pre pubertal 47 hydroxy vitamin D 47 coronary CT angiography 47 monocyte chemoattractant protein 47 epididymal 47 antioxidant supplementation 47 transabdominal 47 pT2 47 colorectal polyps 47 cytological 47 spirometric 47 XLHED 47 regression coefficient 47 distant metastasis 47 serous ovarian cancer 47 thyrotropin levels 47 efficacy evaluable 47 HIV tropism 47 androgen ablation 47 thickness IMT 47 laterality 47 carotid artery blockage 47 immunochemical 47 locoregional disease 47 remnant lipoproteins 47 Oncotype DX Recurrence Score 47 Insulin sensitivity 47 axonal degeneration 47 corneal curvature 47 syndromal 47 baseline LDH 47 B7 H4 47 socioeconomic status SES 47 highest quintile 47 proband 47 genotypic 47 periodontal infections 47 Hurthle cell 47 % CI #.#-#.# [005] 47 histological diagnosis 47 glycoprotein IIb IIIa inhibitors 47 Poisson regression 47 BMD measurements 47 potentially modifiable 47 Histologic 47 anti angiogenic agents 47 medial frontal cortex 47 idiopathic myelofibrosis 47 tumoral 47 calcaneus 47 p = .# [002] 47 leukocyte counts 47 neoadjuvant 47 molecular abnormalities 47 limiting generalizability 47 genetic loci 47 postoperative chemotherapy 47 DXA scan 47 MTT assay 47 activate p# 47 contralateral breast 47 correlational 47 Prostate specific antigen 47 dose ionizing radiation 47 genetic polymorphisms 47 Fractional Flow Reserve 47 invasive ductal 47 malignant nodules 47 pathologic 47 pituitary adenomas 47 Prognostic significance 47 nucleic acid sequence 47 underlying pathophysiology 47 Subgroup analysis 47 stress echocardiography 47 esophageal carcinoma 47 laser atherectomy 47 RBC folate 47 breast cancer metastasis 47 dose Iluvien 47 diabetic hypertensive 47 extensive metabolizers 47 perioperative morbidity 47 node metastases 47 arterial thrombotic 47 malignant neoplasm 47 left ventricular diastolic 47 stage IIIA 47 cirrhotic 47 methotrexate monotherapy 47 stepwise logistic regression 47 nonhereditary 47 mitral annular 47 glial tumors 47 PCA3 scores 47 KRAS mutations occur 47 NNRTI resistance 47 breast carcinoma 47 D dimer 47 Cystatin C 46 serum cotinine 46 druggable targets 46 surgical debulking 46 Genetic variation 46 HLA DR4 46 intraclass correlation coefficient 46 pharmacodynamic PD 46 femoral neck BMD 46 TMEM density 46 recurrent venous thromboembolism 46 serum homocysteine 46 ultrasound elastography 46 radiochemotherapy 46 prostatic 46 VLDL cholesterol 46 BRCA2 mutation carriers 46 glycated hemoglobin levels 46 Genetic predisposition 46 granulocyte 46 tumorigenicity 46 ependymoma 46 breast cancer subtypes 46 antiphospholipid antibodies 46 HDL particle 46 MGUS 46 antiretroviral naïve 46 telomerase inhibition 46 intima media thickness IMT 46 anti angiogenic drugs 46 Symptom severity 46 NPM1 mutation 46 #p# [001] 46 cardiac dysfunction 46 histopathologic examination 46 distant metastases 46 aneuploid 46 ventilation perfusion 46 surrogate marker 46 hallux valgus 46 interindividual variability 46 comorbid illnesses 46 ductus venosus 46 #OHD 46 prospective longitudinal 46 thrombophilia 46 nonfasting 46 abnormal clotting 46 sporadic ALS 46 Lp lipoprotein 46 thyroid nodule 46 ulcer healing 46 periprocedural 46 #p# [003] 46 EBV infection 46 bronchoalveolar lavage 46 eNO 46 fluoroquinolone resistance 46 serum uric acid 46 EBRT 46 gene APOE 46 #.#mmol l [002] 46 sentinel lymph node biopsy 46 PARP inhibition 46 subset 46 somatic mutations 46 CD# + [001] 46 VTEs 46 immunosuppressive regimens 46 NGAL 46 bivariate analyzes 46 #T# L1 46 macroalbuminuria 46 observational cohort study 46 immunofluorescent 46 TMEM 46 tissue perfusion 46 preoperative chemotherapy 46 statistically significant predictor 46 LDL cholesterol concentrations 46 serum lactate 46 endocervical 46 cholesterol esters 46 MYH9 gene 46 GSTP1 46 psychiatric comorbidity 46 tirofiban 46 virologic responses 46 bioengineered tissue 46 primary aldosteronism 46 ascending aortic 46 predictive 46 prospectively randomized 46 osteoblastic 46 probabilistic modeling 46 metastatic lesion 46 diagnostic modality 46 null hypothesis 46 AML MDS 46 nmol l 46 hematopoietic cell 46 sarcomatoid 46 heritable traits 46 FDG uptake 46 RNFL 46 AtherOx 46 vivo molecular imaging 46 polypoid 46 nanomolar 46 arterial oxygen saturation 46 medication nonadherence 46 clinically insignificant 46 mRCC 46 uPA 46 resectable 46 individualizing 46 osteoid 46 ER CHOP 46 angiographically 46 statistical correlations 46 β blockers 46 noncognitive 46 antiplatelet therapies 46 calcaneal fractures 46 rho = 46 authors conclude 46 serum markers 46 DAS# scores 46 rs# [002] 46 node dissection 46 elevated fasting glucose 46 serum GGT 46 Aspergillus infections 46 white matter hyperintensities 46 plasma adiponectin 46 microRNA biomarkers 46 CK MB 46 JAK2 V#F 46 Framingham Offspring Study 46 interrater reliability 46 murine models 46 elevated IOP 46 MDCT angiography 46 DNA methylation patterns 46 Gag polymorphisms 46 micrometastases 46 invasive bladder 46 HLA DQ2 46 elacytarabine